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The ketogenic diet is a high-fat, low carbohydrate, adequate protein diet, 
developed in the 1920s for the management of intractable seizure disorders in 
children. To evaluate efficacy and tolerability of the classic ketogenic diet, we 
analyzed records of the children  started on the diet from 1999 to 2006 at the 
Mofid children’s hospital.
Materials & Methods 
 The subjects were 87 children, mean age 55 months. Before initiation of the 
diet, 55% of the patients had seizures, at least 1-4 times per day, 36% - 5 or more 
per day and 9% - 2 to 4 times per week. Mean number of  Anti Epileptic Drugs 
(AEDs) tried for them was 8 and 67% were receiving three or more drugs.
Results 
The ketogenic diet showed drastic improvement, with at least 50% reduction 
in seizure frequency in 87% of our patients, 39% of whom showed complete 
seizure control in the third month. After one year, in 80% of the patients who 
returned, improvement continued, with 26% of them being seizure free; besides, 
23% had one AED decreased, 36% had two or three AEDs decreased, and 25% 
(one child) had all AEDs discontinued. Of the 30 improved cases, 20%, at the 
end of the first year, had improved behavior as well, and 23% of them had 
become more alert. The median diet duration of the improved group was 15 
months.
Conclusion
The improvement in our patients, low side effects, and the duration of diet 
by families reveal that the ketogenic diet can still be a very useful alternative 
therapy in certain epileptic children. 
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Introduction  
Seizure disorders in childhood are a frequently occurring neurologic problem (1). 
The prevalence of single and recurrent nonfebrile seizure in children aged under 10 
years, ranges from 5.2 to 8.1 per 1000.(2) Antiepileptic drugs (AEDs) are primary 
treatment modalities and, in most children, provide good seizure control. However, 
more than 25% of children with seizure disorders either have intractable seizures 
or suffer from significant adverse effects secondary to medication. Standard AEDs 
produce side effects in 50% or more of patients and are associated with a number of 
chronic toxicity syndromes; besides, only a limited number of children benefit from 
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surgical therapy (2).
The classic 4:1 ketogenic diet was devised in 1920 for 
treatment of refractory seizures in children when limited 
AEDs were available. With such a diet, most of the 
calories are provided as fat as heavy cream and butter; 
no sugar is allowed, and vitamins and minerals are 
supplemented. The diet is very rigid and requires strict 
nutritional supervision. Despite continuing interest in 
the diet long-term acceptability, effectiveness should be 
determined (2,3,4). 
In this study, we analyzed the records of 87 patients 
who had been prescribed and had started the diet at 
Mofid children’s hospital (1999 to 2006), to evaluate the 
efficacy and acceptability of the classic ketogenic diet . 
Materials & Methods
The files of 87 children started on the diet at Mofid 
children hospital, between April 1999 and March 
2006, were reviewed by telephone, follow-up with 
parents, nutrition and neurologic clinics notes, used to 
supplement hospital records. We were unable to obtain 
adequate information on 11 patients. Mean follow-
up time was (range 1-24 months) 9.4 ± 9.8 SD. Only 
children who had been refractory to most other forms of 
therapy or those who had had severe adverse reactions to 
AEDs, were offered the diet after the family conditions 
were evaluated and found to be appropriate, regarding 
competency and cooperation.
On the first day following admission to hospital, EEG 
was performed and laboratory studies (CBC, plt count, 
chemistry panel) were carried out. The child fasted in the 
hospital for 24-72h, until 4+ ketonuria was produced. All 
carbohydrate-containing medications were discontinued. 
The diet was started at the classic 4:1 ratio (ratio of 
grams of fat to protein plus carbohydrate). Calories were 
calculated on the basis of age and weight to provide 
appropriate calories and protein intake for growth. 
Younger children were started at the lower ratio (3:1) 
to allow more protein. Fluids were restricted to 75% 
of maintenance level, considering the fact that urine 
specific gravity was not more than 1030 and weight loss 
was not over 1%. Total carbohydrate intake per day was 
not more than 30 gr and not less than 10 gr. Patients were 
observed in the hospital for the signs and symptoms of 
hypoglycemia and severe ketonemia, with blood glucose 
and urine ketone being checked twice a day. When the 
urine ketones reached 4+ or 3+, depending on the child’s 
age, the diet was initiated. The child received one meal 
at one third of total calories, and following toleration, 
was advanced to two third of the total calories for three 
meals and then consumed his or her first full meal (2,5).
Prior to discharge, mothers had been educated, 
supplements were added and AEDs were reduced. After 
discharge, patients received follow up at neurologic and 
nutrition clinics in the first, the third and the sixth month 
and the first, the second and the third year. Assessment 
of seizure control was based on the reports of parents. 




Of the patients, 56% were male and 28% were 
microcephalic; 85% of them had neurologic handicaps, 
mental, physical or both, while 16% were in normal 
neurologic range; 3 of them were suspected of having 
a neurodegenerative process, and 16 patients had static 
specific diagnoses like asphyxia, TORCH, Stroke and 
Sequel of meningitis or encephalitis. There were one 
Turner syndrome and one Tuberos  sclerosis among our 
patients. Mean age at diet initiation was 55 months (55 
months ± 24 SD), range of 17-108 months.
Mean age of seizure onset was 14 months (14 months 
± 17 SD) range neonatal period to 78 months. The 
percentage of different types of seizures in our patients 
were as follows: 29% myoclonic, 25% mixed type, 24% 
partial (including simple or complex), 8% generalized 
tonic clonic, 10% generalized tonic and 3% atonic (table 
1). In 41 patients with EEG data, 24% had EEG features 
consistent with Lennox-Gestaut syndrome (LKS), 12% 
had hypsarrhythmia, 7% had focal epileptic activity and 
others had generalized epileptic activity consisting of 
spikes, sharp waves, spike waves or High Voltage Slow 
Waves (HVSW).
The mean number of AEDs tried before the diet was 8, 
and at diet initiation, 67% of children were receiving 
three or more drugs. The frequency of seizures in 55% 
of the patients was at least 1-4 times/per day, in 36% was 
5 or more times/ per day and 9% of them had seizures 
at least  2-4 times/ per week. Mean follow-up time was 
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9.4 months.
2. Results post diet
Seventy-one percent of patients who returned at the 
end of the first month showed a decrease in seizure 
frequency of at least 50%; 20% become virtually seizure, 
but unfortunately there was no improvement in 29% of 
them. At the end of the third month, acceptable decrease 
in seizure frequency (at least 50%) had occurred in 87% 
of children, of which 39% had complete seizure control. 
At the end of sixth month, in 63% of them, reduced 
seizure frequency was set to continue and all of former 
seizure free patients, also remained seizure free.
After one year, of 80% of patients followed up, 
improvement had continued and 26% of them were 
seizure free; moreover, 44% of the improved group from 
the first month, remained on the diet with acceptable 
seizure control (Figure 1).
Cessation of diet occurred in 5%, because of inability 
or unacceptability; the side effects that necessitated 
cessation however were observed in three cases, two 
with severe infection and one with AEDs toxicity.
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Number of  
patients*
Seizure free 16 13 13 8 7 76
80% reduction 19 22 18 12 8 58
50% reduction 19 14 8 4 1 47
No response 22 7 8 6 0 30
No follow-up 11 2 3 9 14 16
*At the initiation of the diet









1 (17%) 3 (38%) ___ 5 (28%) 3 (16%) 1 (4.5%) Seizure free
3 (50%) ___ ___ 5 (28%) 6 (32%) 7 (32%) 80% reduction
___ 1 (13%) 2 (100%) 4 (22%) 5 (26%) 3 (14%) 50% reduction
2 (33%) 2 (25%) ___ 4 (22%) 5 (26%) 10 (45%) No response
6 8 2 18 19 22 number
*Two patients discontinued the diet
+One patient did not return
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At the end of the sixth month, of the 39 improved 
patients, 23% was using one less AED, while 2.5% (one 
child) had all AEDs discontinued; 20% of 30 improved 
children, at the end of first year, had improved behavior 
as well, and 23% of them became more alert, based on 
the basis of their mothers’ reports.
From our data, there is no relationship between success 
with the diet and age (p=1), type of seizure (P= 0.3384, 
df=3, X2=3.36 and neurologic development (P=0.066, 
X2=3.38, df=1) even though, the diet induced better 
response in normally developed children (P=0.0380, 
X2=4.30, df=1). This indicates that most of neurologically 
normal patients were in the improved group with 
80% reduction in seizure frequency in comparison 
with improved group with  50% reduction in sezure 
frequency..
The median diet time of the improved group, at the end 
of sixth month, was 15 months (15 months ± 10.6 SD) 
and that of the unimproved group was 2.27 months (2.27 
±1.5 SD), with significant statistical difference (P<0.001) 
(figure1).
The diet was effective in 6 of 10 patients with clinical 
and EEG features of LKS (60%), while it showed 
improvement just in 2 of 5 cases with infantile spasm 
with hypsarrhythmia.
Side effects
Side effects are reported here categorized in two groups, 
the early and the late side effects groups; in the first 
week, transient hypoglycemia occurred in 8 children 
(10%) who got better by drinking sweet fluids; moreover, 
mild transient epistaxy occurred in one boy, nausea and 
vomiting in 7 patients (9%) and cessation of diet was 
necessary in one case.
During the first month, frequent vomiting and 
hematemesis in one child led to cessation of the diet.
In the late side effects group, levels of cholesterol and 
triglycerides increased in 2, and there was loss of appetite 
in 2 others. One child developed renal stones after 
the second year of the diet; one showed indications of 
cardiomyopathy in the 15th month, and one had gastritis 
in the first year (based on endoscopy results).
One child had AED toxicity at the sixth month of the 
diet (toxic blood levels of phenoharbital and phenytoin, 
followed by admission due to unconsciousness and 
frequent seizures, and eventually discontinuation of the 
diet.
Discussion 
The Ketogenic diet has been used in children with 
intractable seizures for over 90 years. Epilepsy in 
children can mostly be controlled with one medication; 
those whose seizures cannot be controlled with the 
first, properly used, medication, have a less than 20 
percent chance of their seizures being controlled with 
the second medication. Children with seizures that are 
difficult to control with two medications have only a 25 
to 40 percent chance of their seizures being controlled 
with other medications; this latter group of children, 















  Fig. 1: Diet duration status of patients; those remaining on the diet, those who improved, compared 
to those who did not; 15 did not return after the first year.
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medications, have been termed, by some, as intractable 
or difficult to control(4).
The results of our study are similar to those of a 
previous report of a 10-year prospective follow up 
from this hospital in 1987(6), and also other studies 
of Kinsman(1992), Vining(1996), Schwartz(1989), 
Livingstion(1972) and Swink(1997) (2,3,7,8,9). Of note, 
those studies mentioning either type of seizures (3,6,8,9) 
or sex, age and EEG findings (9) have not shown any 
relationship between the earlier mentioned and response 
to the diet  documented results in agreement with ours.
According to low number of infantile spasms, i.e.only 4, 
we cannot comment precisely on the efficacy of the diet 
about it ; nevertheless, response of 23 infantile spasm 
patients, at Johns Hopkins institution with a 4 year- 
follow up, reported the diet to be a safe well-tolerated 
and effective alternative to other therapies; a lower 
efficacy however was observed when EEG showed 
hyppsarryhthmia(10).
In LKS, better response was seen in myoclonic seizures 
than other types; even in one unimproved patient with 
just 30% reduction in seizure frequency, the maximum 
reduction was observed in drop attacks. In comparison, 
other researches reported remarkable reduction in 
myoclonic, atonic and atypical absence type (11); 
moreover, even after 36 hours fasting in the Freeman 
study has induced more than 50% reduction was seen in 
myoclonic and atonic attacks (12).
The knowledge and experience of dieticians are 
fundamental to this diet; our nutritionist planned the diet 
keeping in mind regional dietary habits and encouraging 
the desired attitude and acceptance in child and family.
Consistent with results of other researches, our study 
reveals good association between continuation of the 
diet and therapeutic response (3,6); however ability to 
remain on/adhere to the diet, affects seizure control.
There are many limitations in this study including lack of 
information about some patients especially after the first 
year, retrospective evaluation and reliance on parental 
reports.
The mechanism by which this regimen controls 
convulsions is still unknown; it is independent of 
respiratory or metabolic acidosis and the accumulation 
of ketone bodies, and the anticonvulsant effects are not a 
result of the direct effect of ketone bodies on voltage and 
ligand-gated ion channels. Switch in cerebral metabolism 
involving the use of B-hydroxybutyrate instead of glucose 
as a energy substrate may reduce neuronal excitability 
(1,13). There are several hypotheses regarding this; 
alteration in either the metabolism of brain aminoacids 
or extracellular milieu (13,14) and enhancement on 
activation of mitochondrial uncoupling protein which 
exert neuroprotective effets (15).The large number of 
children who now are free (or nearly free) of medications, 
are free (or nearly free) of seizures and are currently off 
the diet should encourage search for the mechanisms by 
which the diet not only suppresses seizures but perhaps 
also alters the underling epileptogenicity of the brain. (4) 
Renal stones developed in one patient (1.5%), reported 
to be up to10% in other studies (4); however with more 
prolonged diet (mean 7.8 years), this figure reached up to 
25% (16). Risk factors for renal stones include lower age 
at the initiation of the diet (our patient was 2 years old) 
and hypercalciuria (17). Although occasionally patients 
need lithotripsy or surgical removal of the stones, this 
was no reason for cessation of diet in children whose 
seizures had improved (4). Cardiac complications of the 
ketogenic diet in the absence of selenium deficiency have 
not been reported, while prolonged QT interval (QTC), 
cardiac chamber enlargement and cardiomyopathy have 
been found. There was a significant correlation between 
prolonged QTC and both low serum bicarbonate and 
high beta-hydroxybutyrate  (18).
One patient with severe cardiomyopathy in 15th month 
of diet, normalized when the diet was discontinued.
Lack of double blind studies is an issue preventing wider 
acceptance by the medical profession. Double blind 
studies help elimination, placebo effect, spontaneous 
remission and researchers expectations of prejudice 
about their observations (19).
Another limitation of the diet is strictness;  furthermore, 
Atkins diet type has been supposed by other specialists 
since there is no need to admit the child and it is easier 
to administer and will not require a more rigorous diet. 
If the child does not respond, they initiate the traditional 
ketogenic diet . It is of interest to note that the Atkins diet 
also can reduce seizure frequency in focal and multifocal 
epilepsy (16).
Another alternative is the low-glycemic-index diet with 
more liberal total carbohydrate intake but restricted to 
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foods that produce relatively little increase in blood 
glucose(glycemic index <50); Ten of 20 patients treated 
with this regimen experienced over 90% reduction in 
seizure frequency (20).
One study aiming to establish a dose-response relation 
for the efficacy of ketogenic diet, showed that the 
conventional 4:1 diet does not confer the greatest level 
of seizure protection. They concluded that a 6:1 diet 
which shows no evidence of neurotoxicity, is maximally 
efficacious in rats (21). In the future, it may be possible 
to offer a range of ketogenic diets consisting different 
ratios of carbohydrate and fat depending on characteristic 
features of patients or their seizure disorders.
Our study showed good effectiveness, appropriate 
acceptance, low side effects and improvement in 
behavioral and cognitive scales in our patients. Since 
so many questions need to be answered about the diet, 
its adverse effects should be always considered in 
comparison to the impacts of frequent seizures and side 
effects of AEDs.
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